Deerfield Management Company, L.P. (Series C) Delcath Systems, Inc. Call Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $3.95 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
100Shares Held
12.1MCall Options Held
79KPut Options Held
53.3K-
Vanguard Group Inc Valley Forge, PA1.39MShares$17 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA750KShares$9.15 Million2.59% of portfolio
-
Exodus Point Capital Management, LP New York, NY699KShares$8.53 Million0.09% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA557KShares$6.8 Million0.0% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY539KShares$6.57 Million0.1% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $105M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...